0
0
11/14/23 at 12:02pm
Organization
Hcplive.com
Author
Kevin Kunzmann
31 words
0
Comments
Sanyal discusses the makeup of retatrutide and its potential for patients with fatty liver disease and comorbid metabolic conditions.
You are the first to view
https://www.hcplive.com/view/arun-sanyal-retatrutide-glp-1-agonists-masld
Create an account
or login to join the discussion